100% correct Suzuki. It was hard enough to recruit 40 odd patients to enrol in the PANCO study if everyone recalls. Imagine telling terminally ill patients with months to live that half of you will get the Oncosil device and the other half a placebo! And it would be randomised! There would have been no one enrolled in the trial. Pure and simple.
Glad the company set the parameters and protocols of the trial. As they know what they are doing and know their device best. The naysayers as usual don’t have a clue what they are on about.
Cheers
GW
OSL Price at posting:
12.5¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)